Su-Chun Zhang received his MD (1984) and MS (1989) in China, and PhD (1996) in Canada. Following postdoctoral training, he began his assistant professor in 2001 and is now Steenbock Professor in Behavioral and Neural Sciences at University of Wisconsin-Madison. He is also professor and director of the Signature Program in Neuroscience and Behavioral Disorders at Duke-NUS Medical School, Singapore. His group has developed technology to guide human pluripotent stem cells to functionally specialized nerve cell types. He is dissecting mechanisms of and developing therapeutics for neurological conditions like Parkinson’s disease. Dr. Zhang is a founder of the WiCell Institute and BrainXell, Inc.
Co-PI (Core Leadership)
Su-Chun Zhang, PhD
University of Wisconsin-Madison
Su-Chun Zhang received his MD (1984) and MS (1989) in China, and PhD (1996) in Canada. Following postdoctoral training, he began his assistant professor in 2001 and is now Steenbock Professor in Behavioral and Neural Sciences at University of Wisconsin-Madison. He is also professor and director of the Signature Program in Neuroscience and Behavioral Disorders at Duke-NUS Medical School, Singapore. His group has developed technology to guide human pluripotent stem cells to functionally specialized nerve cell types. He is dissecting mechanisms of and developing therapeutics for neurological conditions like Parkinson’s disease. Dr. Zhang is a founder of the WiCell Institute and BrainXell, Inc.
